Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Love Pharma Inc. (LUV.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
0.02500.0000 (0.00%)
At close: 11:53AM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in CAD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/31/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.3000
52 Week Low 30.0250
50-Day Moving Average 30.0415
200-Day Moving Average 30.1091

Share Statistics

Avg Vol (3 month) 316.14k
Avg Vol (10 day) 314.41k
Shares Outstanding 5504.23M
Implied Shares Outstanding 6N/A
Float 8489.39M
% Held by Insiders 12.98%
% Held by Institutions 10.00%
Shares Short (Jan 12, 2023) 415.58k
Short Ratio (Jan 12, 2023) 40.21
Short % of Float (Jan 12, 2023) 4N/A
Short % of Shares Outstanding (Jan 12, 2023) 40.00%
Shares Short (prior month Dec 14, 2022) 4296.15k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jan 21, 2018
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.20%
Return on Equity (ttm)-142.66%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-4.24M
Diluted EPS (ttm)-0.0220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.1M
Total Cash Per Share (mrq)0
Total Debt (mrq)91.38k
Total Debt/Equity (mrq)3.71
Current Ratio (mrq)3.54
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-2.42M
Levered Free Cash Flow (ttm)-909.29k
Advertisement
Advertisement